OMRON Corp

6645: XTKS (JPN)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|>hLOCK|<%xLLOCK|KCJ#WKL

Omron Earnings: Profit Miss as HCB Drags; 22% Cut in Our Fair Value Reflects Long-Term Shift

Omron's June-quarter sales rose 3.1% year on year, with the operating margin at 3.4%. Industrial automation grew 10.5% yearly, offsetting a 17.9% yearly decline in healthcare, or HCB. The company maintained its fiscal 2025 (ending March 2026) sales growth guidance of 2.3%-4.1%.

Sponsor Center